Cite
Association of Renin Angiotensin Aldosterone System Inhibitors and Outcomes of Hospitalized Patients With COVID-19.
MLA
Gupta, Neha, et al. “Association of Renin Angiotensin Aldosterone System Inhibitors and Outcomes of Hospitalized Patients With COVID-19.” Critical Care Medicine, vol. 50, no. 10, Oct. 2022, pp. e744–58. EBSCOhost, https://doi.org/10.1097/CCM.0000000000005627.
APA
Gupta, N., Settle, L., Brown, B. R., Armaignac, D. L., Baram, M., Perkins, N. E., Kaufman, M., Melamed, R. R., Christie, A. B., Danesh, V. C., Denson, J. L., Cheruku, S. R., Boman, K., Bansal, V., Kumar, V. K., Walkey, A. J., Domecq, J. P., Kashyap, R., Aston, C. E., & Mesland, J.-B. (2022). Association of Renin Angiotensin Aldosterone System Inhibitors and Outcomes of Hospitalized Patients With COVID-19. Critical Care Medicine, 50(10), e744–e758. https://doi.org/10.1097/CCM.0000000000005627
Chicago
Gupta, Neha, Lisa Settle, Brent R. Brown, Donna L. Armaignac, Michael Baram, Nicholas E. Perkins, Margit Kaufman, et al. 2022. “Association of Renin Angiotensin Aldosterone System Inhibitors and Outcomes of Hospitalized Patients With COVID-19.” Critical Care Medicine 50 (10): e744–58. doi:10.1097/CCM.0000000000005627.